Invention Grant
- Patent Title: Raf inhibitors
- Patent Title (中): Raf抑制剂
-
Application No.: US13105957Application Date: 2011-05-12
-
Publication No.: US08232283B2Publication Date: 2012-07-31
- Inventor: Andreas Schoop , Alexander Backes , Joachim Vogt , Lars Neumann , Jan Eickhoff , Stefan Hannus , Kerrin Hansen , Peter Amon , Igor Ivanov , Matthias Borgmann , Chase Smith , Arthur F. Kluge , Krishan Murthi , Rebecca Casaubon
- Applicant: Andreas Schoop , Alexander Backes , Joachim Vogt , Lars Neumann , Jan Eickhoff , Stefan Hannus , Kerrin Hansen , Peter Amon , Igor Ivanov , Matthias Borgmann , Chase Smith , Arthur F. Kluge , Krishan Murthi , Rebecca Casaubon
- Applicant Address: US MA Watertown
- Assignee: Forma Therapeutics, Inc.
- Current Assignee: Forma Therapeutics, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Gearhart Law, LLC
- Priority: EP08103665 20080422
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/505 ; A61P35/00
Abstract:
The present invention provides derivatives of pyrido[2,3-d]pyrimidin-7-one. These compounds are inhibitors or kinases such as Raf, including compounds that show anti-proliferative activity, including against tumor cells, and are useful in the treatment of diseases including cancer.
Public/Granted literature
- US20110257207A1 RAF INHIBITORS Public/Granted day:2011-10-20
Information query
